engagedIN Hires Healthcare and Technology Executive, Josh Leichter, to Support Growth and Expansion of Offerings
Natera, Inc. (NTRA)
Last natera, inc. earnings: 2/26 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.natera.com
Company Research
Source: PR Web
SANTA CRUZ, Calif. (PRWEB) July 18, 2018 engagedIN, a neuroscience-based design and technology firm, today announced the appointment of Josh Leichter, a 20-year veteran executive and advisor to life sciences, technology and healthcare companies, as Chief Operating Officer and General Counsel. engagedIN helps its clients and customers empower their employees, customers and end users to change behavior towards health and well being.Leichter has spent his professional career helping to build companies focused on the health of their customers, most recently as VP of Legal and Corporate Affairs for Natera, Inc., a billion-dollar, publicly-traded molecular genetics diagnostics firm. Leichter sat on Natera's executive committee through a period of 5-fold growth of the company's employee base and revenues. He also oversaw Natera's successful initial public offering in 2015. Prior to Natera, Leichter was an executive at Cubist, Inc., which sold to Merck for over $8 billion. Leichter brings
Show less
Read more
Impact Snapshot
Event Time:
NTRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRA alerts
High impacting Natera, Inc. news events
Weekly update
A roundup of the hottest topics
NTRA
News
- New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast CancerBusiness Wire
- Natera to Report its First Quarter 2024 Results on May 9 [Yahoo! Finance]Yahoo! Finance
- Natera to Report its First Quarter 2024 Results on May 9Business Wire
- Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage [Yahoo! Finance]Yahoo! Finance
- Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg ShortageBusiness Wire
NTRA
Earnings
- 2/28/24 - Beat
NTRA
Sec Filings
- 5/3/24 - Form 4
- 5/1/24 - Form 4
- 5/1/24 - Form 4
- NTRA's page on the SEC website